End-stage renal disease in African Americans with lupus nephritis is associated with APOL1
- PMID: 24504811
- PMCID: PMC4002759
- DOI: 10.1002/art.38220
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1
Abstract
Objective: Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) that exhibits familial aggregation and may progress to end-stage renal disease (ESRD). LN is more prevalent among African Americans than among European Americans. This study was undertaken to investigate the hypothesis that the apolipoprotein L1 gene (APOL1) nephropathy risk alleles G1/G2, common in African Americans and rare in European Americans, contribute to the ethnic disparity in risk.
Methods: APOL1 G1 and G2 nephropathy alleles were genotyped in 855 African American SLE patients with LN-ESRD (cases) and 534 African American SLE patients without nephropathy (controls) and tested for association under a recessive genetic model, by logistic regression.
Results: Ninety percent of the SLE patients were female. The mean ± SD age at SLE diagnosis was significantly lower in LN-ESRD cases than in SLE non-nephropathy controls (27.3 ± 10.9 years versus 39.5 ± 12.2 years). The mean ± SD time from SLE diagnosis to development of LN-ESRD in cases was 7.3 ± 7.2 years. The G1/G2 risk alleles were strongly associated with SLE-ESRD, with 25% of cases and 12% of controls having 2 nephropathy alleles (odds ratio [OR] 2.57, recessive model P = 1.49 × 10(-9)), and after adjustment for age, sex, and ancestry admixture (OR 2.72, P = 6.23 × 10(-6)). The age-, sex-, and admixture-adjusted population attributable risk for ESRD among patients with G1/G2 polymorphisms was 0.26, compared to 0.003 among European American patients. The mean time from SLE diagnosis to ESRD development was ∼2 years earlier among individuals with APOL1 risk genotypes (P = 0.01).
Conclusion: APOL1 G1/G2 alleles strongly impact the risk of LN-ESRD in African Americans, as well as the time to progression to ESRD. The high frequency of these alleles in African Americans with near absence in European Americans explains an important proportion of the increased risk of LN-ESRD in African Americans.
Copyright © 2014 by the American College of Rheumatology.
Similar articles
-
Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.Am J Nephrol. 2015;42(2):99-106. doi: 10.1159/000439448. Epub 2015 Sep 8. Am J Nephrol. 2015. PMID: 26343748 Free PMC article.
-
APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus.Lupus. 2023 May;32(6):763-770. doi: 10.1177/09612033231172660. Epub 2023 Apr 27. Lupus. 2023. PMID: 37105192 Free PMC article.
-
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.Kidney Int. 2018 Sep;94(3):599-607. doi: 10.1016/j.kint.2018.03.017. Epub 2018 Jun 7. Kidney Int. 2018. PMID: 29885931 Free PMC article.
-
APOL1 kidney risk alleles: population genetics and disease associations.Adv Chronic Kidney Dis. 2014 Sep;21(5):426-33. doi: 10.1053/j.ackd.2014.06.005. Adv Chronic Kidney Dis. 2014. PMID: 25168832 Free PMC article. Review.
-
APOL1 and nephropathy progression in populations of African ancestry.Semin Nephrol. 2013 Sep;33(5):425-32. doi: 10.1016/j.semnephrol.2013.07.004. Semin Nephrol. 2013. PMID: 24119848 Free PMC article. Review.
Cited by
-
ESRD from lupus nephritis in the United States, 1995-2010.Clin J Am Soc Nephrol. 2015 Feb 6;10(2):251-9. doi: 10.2215/CJN.02350314. Epub 2014 Dec 22. Clin J Am Soc Nephrol. 2015. PMID: 25534208 Free PMC article.
-
Precision medicine in lupus nephritis: can biomarkers get us there?Transl Res. 2018 Nov;201:26-39. doi: 10.1016/j.trsl.2018.08.002. Epub 2018 Aug 10. Transl Res. 2018. PMID: 30179587 Free PMC article. Review.
-
Association Between APOL1 Genotype and Need for Kidney Replacement Therapy in Patients Without Diabetes: Does Age Matter?Am J Kidney Dis. 2020 Feb;75(2):294-296. doi: 10.1053/j.ajkd.2019.08.017. Epub 2019 Dec 16. Am J Kidney Dis. 2020. PMID: 31837887 Free PMC article. No abstract available.
-
Good Long-Term Prognosis of Lupus Nephritis in the High-Income Afro-Caribbean Population of Martinique with Free Access to Healthcare.J Clin Med. 2022 Aug 19;11(16):4860. doi: 10.3390/jcm11164860. J Clin Med. 2022. PMID: 36013099 Free PMC article.
-
Lessons from precision medicine in rheumatology.Mult Scler. 2020 Apr;26(5):533-539. doi: 10.1177/1352458519884249. Epub 2020 Jan 22. Mult Scler. 2020. PMID: 31965913 Free PMC article. Review.
References
-
- Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet. 2008;40:211–6. - PubMed
-
- Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358:900–9. - PubMed
-
- Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009;41:1234–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 DK042086/DK/NIDDK NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- K08 AI083790/AI/NIAID NIH HHS/United States
- R01-AR-060861/AR/NIAMS NIH HHS/United States
- P60-AR-30692/AR/NIAMS NIH HHS/United States
- R01 AI024717/AI/NIAID NIH HHS/United States
- P30-AR-053483/AR/NIAMS NIH HHS/United States
- P01-AI-083194/AI/NIAID NIH HHS/United States
- P30-GM-103510/GM/NIGMS NIH HHS/United States
- UL1 TR001070/TR/NCATS NIH HHS/United States
- P60-AR-062755/AR/NIAMS NIH HHS/United States
- P60 AR053308/AR/NIAMS NIH HHS/United States
- P01-DK-55546/DK/NIDDK NIH HHS/United States
- U01-AI-101934/AI/NIAID NIH HHS/United States
- P30 GM103510/GM/NIGMS NIH HHS/United States
- R01 DK084149/DK/NIDDK NIH HHS/United States
- R01 DK070941/DK/NIDDK NIH HHS/United States
- UL1 TR000150/TR/NCATS NIH HHS/United States
- K24-AR-002138/AR/NIAMS NIH HHS/United States
- AI-083194/AI/NIAID NIH HHS/United States
- R01-AR-043814/AR/NIAMS NIH HHS/United States
- P01 DK055546/DK/NIDDK NIH HHS/United States
- UL1 RR024999/RR/NCRR NIH HHS/United States
- P30 AR053483/AR/NIAMS NIH HHS/United States
- UL1 TR000165/TR/NCATS NIH HHS/United States
- UL1-RR-024999/RR/NCRR NIH HHS/United States
- P60-AR-053308/AR/NIAMS NIH HHS/United States
- UL1-TR-000004/TR/NCATS NIH HHS/United States
- UL1-RR-029882/RR/NCRR NIH HHS/United States
- UL1 RR025741/RR/NCRR NIH HHS/United States
- K08-AI-083790/AI/NIAID NIH HHS/United States
- R01-DK-070941/DK/NIDDK NIH HHS/United States
- K24-AR-02175/AR/NIAMS NIH HHS/United States
- AI-024717/AI/NIAID NIH HHS/United States
- R01 AR043814/AR/NIAMS NIH HHS/United States
- L30-AI-071651/AI/NIAID NIH HHS/United States
- R37 AI024717/AI/NIAID NIH HHS/United States
- R01 AR042460/AR/NIAMS NIH HHS/United States
- R01-AR-052300/AR/NIAMS NIH HHS/United States
- U01 AI101934/AI/NIAID NIH HHS/United States
- UL1-TR-000165/TR/NCATS NIH HHS/United States
- U191082714/PHS HHS/United States
- RC2-AR-058951/AR/NIAMS NIH HHS/United States
- P01-AR-049084/AR/NIAMS NIH HHS/United States
- UL1 RR029882/RR/NCRR NIH HHS/United States
- L30 AI071651/AI/NIAID NIH HHS/United States
- R01-AR-043727/AR/NIAMS NIH HHS/United States
- R01 AR043727/AR/NIAMS NIH HHS/United States
- UL1 RR025755/RR/NCRR NIH HHS/United States
- AR-042460/AR/NIAMS NIH HHS/United States
- UL1-RR-025755/RR/NCRR NIH HHS/United States
- UL1-RR-025741/RR/NCRR NIH HHS/United States
- AR-049084/AR/NIAMS NIH HHS/United States
- I01 BX001834/BX/BLRD VA/United States
- K24 AR002138/AR/NIAMS NIH HHS/United States
- R01 AR052300/AR/NIAMS NIH HHS/United States
- P01 AI083194/AI/NIAID NIH HHS/United States
- R01 AR060861/AR/NIAMS NIH HHS/United States
- DK-084149/DK/NIDDK NIH HHS/United States
- K24 AR002175/AR/NIAMS NIH HHS/United States
- P60 AR030692/AR/NIAMS NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- P30-DK-42086/DK/NIDDK NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- RC2 AR058951/AR/NIAMS NIH HHS/United States
- P60 AR062755/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous